Women Health Hospital - Assiut university
Asyut, 71111, Egypt
NCT Number: NCT03241849
Placenta accreta is an obstetrical complication where the placenta becomes firmly adherent to the uterine wall. Placenta accreta can lead to considerable maternal morbidity and mortality due to hemorrhage, infection, or other surgical complications such as those resulting from hysterectomy. Retained placenta accreta is usually a rare condition, but its prevalence is increasing due to the rise in the rate of deliveries by Cesarean section.
Placenta accreta is a potentially life-threatening obstetric condition that requires a multidisciplinary approach to management. The incidence of placenta accreta has increased and seems to parallel the increasing cesarean delivery rate. Women at greatest risk of placenta accreta are those who have myometrial damage caused by a previous cesarean delivery with either an anterior or posterior placenta previa overlying the uterine scar. Diagnosis of placenta accreta before delivery allows multidisciplinary planning in an attempt to minimize potential maternal or neonatal morbidity and mortality.
Looking for future studies?
Notify Me20 year–40 year
Female
Interventional
Not applicable
Asyut, 71111, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
suturing of the myometrium splitted by the placenta in cases presented by placenta accreta
Time frame: 24 hours
Assiut University
Other
New Surgical Technique To Control Postpartum Hemorrhage Due To Placenta Accreta
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06219538
Cesarean Section Complications, Female Urogenital Diseases
Norfolk, Virginia, United States
View Trial DetailsNCT06255496
Blood Loss Massive, Cardiovascular Diseases
Rochester, New York, United States
View Trial DetailsNCT04117243
Female Urogenital Diseases and Pregnancy Complications, Hemorrhage
Cairo, Egypt
View Trial DetailsNCT06253832
Blood Loss Massive, Female Urogenital Diseases and Pregnancy Complications
Manouba, Tunis Governorate, Tunisia
View Trial Details